Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
Active, not recruiting · NCT04041310 · Registry updated 2026-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-13 | NCT04041310 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| Nouscom SRL | 1 |
46 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.